£107.98

Springer Glycerophospholipids in the Brain: Phospholipases A2 in Neurological Disorders

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

New to our records — first sighting 17 days ago. We'll learn its rhythm.

17 days of data · current price £108

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 17 days • 17 data points

Historical
Generating forecast...
£107.98 £102.58 £104.74 £106.90 £109.06 £111.22 £113.38 02 May 2026 06 May 2026 10 May 2026 14 May 2026 18 May 2026

Price Distribution

Price distribution over 17 days • 1 price levels

Days at Price
17 days 0 4 9 13 17 £108 Days at Price

Price Analysis

Most common price: £108 (17 days, 100.0%)

Price range: £108 - £108

Price levels: 1 different prices over 17 days

Description

Product Description This volume provides a comprehensive description of phospholipid metabolism in brain, activities of phospholipases A2, and their involvement in neurological disorders. The purpose of this book is to present readers with cutting edge information in a lively manner that is useful not only to student and teachers but also to researchers and physicians. From the Back Cover Glycerophospholipids in Brain: Phospholipases A2 in Neurological DisordersAkhlaq A. Farooqui and Lloyd A. Horrocks Glycerophospholipids in Brain: Phospholipases A2 in Neurological Disorders provides a synthesis of material on the metabolism of phospholipids in the brain which has previously only been available in a scattered number of original papers and reviews. Here, the research of over 25 years is collected in one volume from two of the leading researchers in the field― Akhlaq A. Farooqui and Lloyd A. Horrocks Glycerophospholipids in Brain: Phospholipases A2 in Neurological Disorders comprehensively describes: metabolism in brain of glycerophospholipids, including those containing a vinyl ether group (plasmalogens) cutting-edge information on the properties and roles of phospholipases A2 in the central nervous system release by phospholipases A2 of second messengers (arachidonic acid, docosahexaenoic acid, and lysophospholipid) from neural membrane phospholipids and their neurochemical effects on brain metabolism and function involvement of phospholipases A2 in neurological and neuropsychiatric disorders, and the use of phospholipase A2 inhibitors for the treatment of diseases associated with altered phospholipid metabolism methods for the assays of phospholipases A2 and their clinical significance This unique volume will be invaluable not only to those interested in biochemical properties of phospholipases A2, but also their involvement in neurological disorders. Students will benefit from it as a supplement for a range of neuroscience courses. Clinicians will find it invaluable as well for understanding molecular aspects of neurodegeneration in acute neural trauma (stroke) and neurodegenerative diseases (Alzheimer disease) that are mediated by phospholipases A2. The information in Glycerophospholipids in Brain: Phospholipases A2 in Neurological Disorders is presented in a lively manner that has never been attempted until now in this specialized format. It will be the essential text for the authoritative research in the field. About the Authors Akhlaq A. Farooqui and Lloyd A. Horrocks are leaders in the fields of phospholipid metabolism and phospholipases A2 in brain. They have published cutting edge research on phospholipases A2 and their involvement in neurological disorders in brain tissue. In collaboration with Dr. Yutaka Hirashima, they have discovered a plasmalogen-selective phospholipase A2 in brain. They have also studied phospholipids composition of neural membranes and activities of phospholipases A2 in neural membranes. Lloyd A. Horrocks is the founding editor of Molecular and Chemical Neuropathology and has edited seven books.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 September 2014
Listed Since
04 October 2014

Barcode

No barcode data available

Similar Products You Might Like

High Calorie Diet and the Human Brain: Metabolic Consequences of Long-Term Consumption
79% match

High Calorie Diet and the Human Brain: Metabolic Consequences of Long-Term Consumption

Springer

£76.98 11 May 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
78% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.11 18 May 2026
Phospholipid Metabolism in Cellular Signaling
78% match

Phospholipid Metabolism in Cellular Signaling

CRC Press

£90.36 18 May 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
78% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£142.46 18 May 2026
Disorders of Lipid Metabolism
78% match

Disorders of Lipid Metabolism

Springer

£73.85 18 May 2026
Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)
77% match

Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical Implications: 446 (Advances in Experimental Medicine and Biology, 446)

Springer

£107.96 18 May 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
77% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment
77% match

Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment

Springer

£149.64 18 May 2026
Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders
77% match

Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders

Academic Press

£145.99 11 May 2026
77% match

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Academic Press

£157.99 11 May 2026
Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)
76% match

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Springer

£107.98 18 May 2026
Neuroacanthocytosis Syndromes
76% match

Neuroacanthocytosis Syndromes

Springer

£108.63 11 May 2026
Neurovascular Neuropsychology
76% match

Neurovascular Neuropsychology

Springer

£76.38 18 May 2026
Neuropsychiatric Disorders
76% match

Neuropsychiatric Disorders

Springer

£107.98 11 May 2026
Current Hypotheses and Research Milestones in Alzheimer's Disease
76% match

Current Hypotheses and Research Milestones in Alzheimer's Disease

Springer

£107.72 18 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
76% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£111.86 11 May 2026
Heat Shock Proteins and the Brain: Implications for Neurodegenerative Diseases and Neuroprotection: 3
76% match

Heat Shock Proteins and the Brain: Implications for Neurodegenerative Diseases and Neuroprotection: 3

Springer

£149.32 18 May 2026
76% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Academic Press

£137.99 11 May 2026
Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
76% match

Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£77.88 11 May 2026
76% match

Microglial Advances in Neurodegenerative Diseases (Volume 170) (Advances in Immunology, Volume 170)

Academic Press

£135.00 11 May 2026
Genomics, Proteomics, and the Nervous System: 2 (Advances in Neurobiology, 2)
75% match

Genomics, Proteomics, and the Nervous System: 2 (Advances in Neurobiology, 2)

Springer

£146.27 18 May 2026
Novel Trends in Brain Science: Brain Imaging, Learning and Memory, Stress and Fear, and Pain
75% match

Novel Trends in Brain Science: Brain Imaging, Learning and Memory, Stress and Fear, and Pain

Springer

£76.38 19 May 2026
Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders
75% match

Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders

Springer

£107.98 18 May 2026
Central Nervous System Diseases and Inflammation
75% match

Central Nervous System Diseases and Inflammation

Springer

£107.98 11 May 2026